News
Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...
Joe Gebbia, a confidant of the technology billionaire and a Tesla director, is also a leader of the federal cost-cutting team ...
The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by rising obesity and type 2 diabetes incidences, the ...
Hims & Hers Health (HIMS -3.91%) is a telehealth company that offers personalized solutions for its customers. And demand has ...
July kicks off the latter half of 2025, and the first six months of this year have been eventful, to say the least. Yet, the ...
The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...
Biocon eyes weight-loss market in Canada, to file for generic Wegovy, Ozempic’s regulatory approvals
The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other ...
The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
11h
Stocktwits on MSNWegovy for $299? Retail Buzz Erupts As WeightWatchers, Novo Nordisk Expand Obesity Drug PushRetail chatter around WW International surged Tuesday after the company’s expanded collaboration with Novo Nordisk officially ...
WeightWatchers Clinic Members Can Access FDA-Approved Wegovy® for $299 in July, a $200 Savings Offer to Improve Access as WeightWatchers’ Trusted, Science-Backed Approach Continues to Lead the Industr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results